BioViz announced on the 25th that it will hold a grand launch ceremony for its ECM (extracellular matrix) skin reviver brand, Celivion (CELIVION), on the 10th of next month.
BioViz has secured exclusive distribution rights for Celivion, an ECM skin reviver based on acellular allogenic dermis (hADM) manufactured by Allotech. BioViz began domestic sales of Celivion in earnest at the end of May and is concurrently carrying out active branding activities to expand its market share.
As part of various branding efforts for Celivion, this event is expected to be attended by approximately 150 domestic and foreign physicians and will include lectures, panel discussions, and celebratory performances.
A BioViz official stated, "Celivion is evaluated as a premium-grade product with superior quality compared to competitors among ECM products," and explained that it is a next-generation ECM product designed to enhance biocompatibility. Unlike existing cosmetic-focused ECM skin boosters, Celivion emphasizes the recovery and regeneration of skin tissue, positioning it as a 'skin reviver' product."
Notably, the product has been evaluated for preserving the ECM structure and key proteins intact by applying a low-temperature process (allo-PELT method), thereby improving tissue recovery and regeneration efficiency.
Based on its branding and marketing capabilities, BioViz is rapidly expanding its domestic dermatology and plastic surgery channels. Additionally, the increasing number of foreign tourists visiting Korean dermatology clinics for procedures is expected to contribute to revenue growth. The company plans to gradually advance Celivion's entry into overseas markets by leveraging its global network established through skin booster and filler sales.
Yang Jun-ho, CEO of BioViz, said, "In addition to our existing business areas such as medical cosmetics, skin boosters, and fillers, the rapidly growing ECM skin reviver market is now contributing additional revenue, resulting in significant year-over-year corporate performance growth." He added, "Moving forward, we will continue to strengthen our competitiveness in both domestic and international markets through sustained new product development and expansion of our product portfolio."
Meanwhile, BioViz was established in July 2018 and specializes in the research, development, manufacturing, and sale of skin booster (Skin Booster) and filler (Filler) products using hyaluronic acid (HA) and various other materials.
in STOCK
